Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
05/1987
05/07/1987WO1987002668A1 Novel pharmacological compounds
05/06/1987EP0221041A2 Benzimidazole derivatives, process for their preparation and their pharmaceutical use
05/06/1987EP0220297A1 Nitrogen-containing heterocycles.
04/1987
04/29/1987EP0219926A2 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
04/28/1987US4661590 Bactericides
04/21/1987CA1220723A1 Oxathiazinone cosmetic composition for the treatment of hair and skin
04/14/1987US4658037 Rheumatic diseases
04/09/1987WO1986007359A3 Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
04/07/1987US4656175 Method of treating aggressive behavior and psychotic conditions employing 1-piperazinocarboxylates
04/07/1987US4656167 Naphthoxazines and their use as psychostimulating and antidepressant agents
04/07/1987US4656166 Antibiotic compounds derived from cephalosporins, process for their production and pharmaceutical compositions
04/01/1987CN86104358A Method for preparing ortho-azonaphthalene compound
03/1987
03/24/1987US4652267 Derivatives of N-oxiranemethane N,N,N-trialkylammonium, their preparation method and their use for the treatment of polyhydroxylated and polyminated polymers
03/18/1987EP0214462A2 3,7-Disubstituted-3-cephem compounds and processes for production of the same
03/11/1987EP0213570A2 Glycolurile derivatives and their use as polymer stabilizers
03/11/1987CN86105998A 3.7-disubstituted-3-cephem compounds and processes for production of the same
03/11/1987CN86105870A Blood vessel tension peptide protoenzyme inhibitor with 5-amino-2.5-disubstituted-4-hydroxy pentacarboxyl
03/04/1987EP0212903A2 Polypeptide derivatives containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
03/03/1987US4647658 Process for preparing aminohydroxycephamcarboxylates
03/03/1987CA1218650A1 Process for the synthesis of pyrido-imidazo- rifamycins
02/1987
02/26/1987WO1987001116A1 Process for preparing cephalosporin intermediates
02/25/1987EP0211656A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
02/25/1987EP0211526A2 Cephalosporins, their preparation and formulations
02/25/1987EP0211416A2 Novel HMG-CoA reductase inhibitors
02/25/1987CN86101087A Benzoyl urea compounds process for production
02/18/1987CN86104805A Ceph-3-ene-4-carboxylic acid derivatives
02/12/1987WO1987000838A1 Novel benzothiazine derivatives
02/11/1987CN86105509A Benzoyl esters
02/11/1987CN85106495A Heterocyclic compounds
02/04/1987CN86104789A Para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylamino-propanol-2-s having beta-receptor blocking properties
02/04/1987CN86104383A Process for the preparation of a silver-containing catalyst
02/04/1987CN86102630A T-amino-3-propenylcephalosporanic acid and esters thereof
02/03/1987CA1217487A1 Process for the preparation of alkylenediamine derivatives
01/1987
01/31/1987CN85101682A Process for the preparation of beta-lactam antibiotics and their use
01/29/1987DE3625251A1 Novel application of dibenzo[cd,f]indoles
01/27/1987US4639448 7-amino-3-[substituted vinyl]-3-cephem-4-carboxylates having antimicrobial activity
01/27/1987US4639266 Plant protection agents based on 1,2,4-triazole derivatives and also new derivatives of 1,2,4-triazole
01/24/1987CN85101490A Imidazodiazepine derivatives
01/21/1987CN86105663A Chemical compounds
01/21/1987CN86104690A Antibiotic method and formulations
01/21/1987CN85106755A Thiazolidine derivative and processes for preparing the same
01/20/1987US4638078 Arylcyclobutenyl amido alkenoic acids and salts thereof
01/14/1987EP0208517A2 6-Oxo-pyridazinyl compounds
01/13/1987US4636508 5-pyrimidinecarboxyamides and treatment of leukemia therewith
01/13/1987CA1216577A1 Crystalline 7-(r)-amino-3-(1-pyridiniummethyl) ceph -3-em-4-carboxylate
01/07/1987EP0207550A1 Process for the preparation of a silver-containing catalyst
01/07/1987CN86102767A 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith
01/06/1987CA1216285A1 Cephalosporin ester derivatives, their production and use
12/1986
12/30/1986US4632940 N-substituted 1-(4'-alkylsulfonylphenyl)-2-amino-1,3-propanediols, pharmaceutical compositions containing them, having local anesthetic activity
12/30/1986US4632918 17-(1-(2-aminothiazol-4-yl)-1-(substituted)alkenecarboxamido)-3 -(quaternary ammonium)methyl-3-cephem-4-carboxylate
12/30/1986EP0206999A2 Microbiocide compounds
12/30/1986EP0205511A1 New piperazine derivatives
12/30/1986CA1215976A1 New process for the synthesis of imidazo rifamycins
12/30/1986CA1215971A1 Cephalosporin derivatives
12/23/1986US4631282 Antihypertensive chromans and chromenes
12/18/1986WO1986007359A2 Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
12/17/1986EP0205403A1 Process for the manufacture of cyclopropylamine
12/17/1986EP0205272A2 Cinnoline derivatives
12/17/1986CN86100170A Process for prepn. of propanol derivatives
12/10/1986EP0204657A2 Process for the production of 7-aca derivatives
12/03/1986CN85108210A Process for preparing antibiotic a80190
12/02/1986US4626595 Oxirane intermediates of 1-hydroxyethyl azole compounds
12/02/1986US4626533 7-(2-thienylacetamido)-3-acylaminomethyl-cephalosporins
11/1986
11/26/1986EP0202441A1 Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions
11/25/1986US4624953 1-piperazinocarboxylates and pharmaceutical compositions containing them
11/25/1986US4624948 Crystalline modification of ceftazidim
11/25/1986US4624946 Treatment of involutional brain syndromes and mental decay
11/25/1986CA1214462A1 Carbapenem derivatives, their preparation and compositions containing them
11/20/1986WO1986006589A1 Removing and recovering plant polyphenols
11/20/1986EP0202046A1 7-Substituted bicyclic pyrazolidinones
11/20/1986EP0201678A1 3-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine, a process for its preparation and pharmaceutical compositions
11/20/1986EP0201623A1 Pharmaceutical compositions for the treatment of involutional brian syndromes and mental decay
11/18/1986CA1214165A1 Pharmaceutical compositions and method of producing alpha.sub.2 antagonism
11/12/1986CN86101792A Process for preparing heterocyclic compounds
11/11/1986US4622321 Oxadiazolylimidazobenzodiazepine, compositions, and method
11/11/1986US4622320 Central nervous system disorders
11/06/1986WO1986006373A1 Nitrogen-containing heterocycles
11/05/1986CN86100122A Process for the preparation of heterocyclic compouds and control pest composition containing this heterocyclic compounds
11/05/1986CN85108120A Process for the preparation of tricyclische pyridinderivate and their use
11/04/1986CA1213580A1 Naphthylglycyl cephalosporin derivatives
10/1986
10/29/1986CN86103619A Process for preparing 7-substituted bicyclic pyrazolidinones
10/28/1986US4620015 Sodium hydride as condensing agent
10/21/1986CA1212957A1 Diphenylazomethines, their preparation and pharmaceutical compositions containing them
10/21/1986CA1212946A1 Chromans and chromenes
10/15/1986EP0197294A2 Beta-lactam antibiotics, process for their preparation and their use as medicaments
10/15/1986EP0197282A1 Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
10/07/1986US4616080 Simplified process of forming crystalline ceftazidime pentahydrate
09/1986
09/24/1986EP0195346A2 3-Aryl uraciles and their use as herbicides
09/16/1986US4612329 Pharmaceutical alpha-aminoalkyl-alpha-alkylphenylacetonitriles
09/10/1986CN86101695A Process for the preparation of beta-lactam antibiotics and their use as medicaments
09/09/1986CA1211125A1 Process for the preparation of aminonitriles useful for the preparation of herbicides
09/02/1986US4609730 Cephalosporin antibiotics
09/02/1986US4609654 Bactericides
09/02/1986US4609653 Crystalline cephem-acid addition salts and processes for their preparation
09/02/1986CA1210756A1 Benzothienyl cephalosporin antibiotics
09/02/1986CA1210702A1 Method and composition to inhibit the growth of streptococcus mutans by the use of saccharin/fluoride combination
08/1986
08/27/1986EP0192060A1 Heterocyclic compounds
08/19/1986CA1210014A1 Diastereomers of 1-ethyl-2-aminomethyl pyrrolidine
08/19/1986CA1209992A1 Process for the preparation of the 5z-isomers of 2,3, 4-trinor-1,5-inter-m-phenylene prostacyclin derivatives
08/12/1986US4605651 Antibiotic amino acid derivatives of cephalosporins